Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Maria Pilar Solis-Hernandez"'
Autor:
Javier Martin-Broto, Jeronimo Martinez-Garcia, David S. Moura, Andres Redondo, Antonio Gutierrez, Antonio Lopez-Pousa, Javier Martinez-Trufero, Isabel Sevilla, Roberto Diaz-Beveridge, Maria Pilar Solis-Hernandez, Amancio Carnero, Marco Perez, David Marcilla, Jesus Garcia-Foncillas, Pablo Romero, Javier Fernandez-Jara, Daniel Lopez-Lopez, Ivan Arribas, Nadia Hindi
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract Cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors demonstrated activity in terms of progression-free survival (PFS) in advanced dedifferentiated liposarcoma (DD-LPS), a sarcoma with CDK4 amplification. CDK4 overexpression is by far more c
Externí odkaz:
https://doaj.org/article/0c66d90901d244e6922dd1f9ea0a3f1f
Autor:
Maria Pilar Solis-Hernandez, Carla Martín, Beatriz García, Natalia Pérez-López, Yolanda García-Mesa, Sara González-Fernández, Olivia García-Suárez, Jesús Merayo, Iván Fernández-Vega, Luis M. Quirós
Publikováno v:
Cells, Vol 10, Iss 8, p 2002 (2021)
Small leucine-rich proteoglycans (SLRPs) regulate different processes and undergo significant alterations in various diseases. Colon carcinomas (CCs) are heterogeneous pathologies with important clinical and molecular differences depending on their l
Externí odkaz:
https://doaj.org/article/d1b7575d26654d9993f211d1d84a45b6
Autor:
Segundo Gonzalez-Rodriguez, Maria Pilar Solis-Hernandez, Alejandra Martínez-Pérez, Seila Lorenzo-Herrero, Christian Sordo Bahamonde, MARIA DANIELA CORTE TORRES, Ivan Fernandez-Vega
Publikováno v:
Scopus
Glioblastoma stands as the most frequent primary brain tumor. Despite the multimodal therapy for glioblastoma patients, the survival rate is very low, highlighting the need for novel therapies that improve patient outcomes. Immune checkpoint blockade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afd5397e94c2c18547040e56ce4b3a46
http://hdl.handle.net/10651/67044
http://hdl.handle.net/10651/67044
Autor:
Carla Martín, Beatriz García, Iván Fernández-Vega, Luis M. Quirós, David Rodríguez, Jesús Merayo, Maria Pilar Solis-Hernandez, Natalia Pérez-López, Ignacio Alcalde
Publikováno v:
Journal of Neuropathology & Experimental Neurology. 80:446-456
The saccharide chains of heparan sulfate appear to be involved in several aspects Alzheimer disease (AD) pathogenesis. Their structural complexity is due to the expression of different isoenzymes. We studied the differential transcription of heparan
Autor:
Javier Martin Broto, Jeronimo Martinez Garcia, David Silva Moura, Andres Redondo, Antonio Gutierrez, Antonio Lopez-Pousa, Javier Martinez-Trufero, Isabel Sevilla, Robert Diaz Beveridge, Maria Pilar Solis-Hernandez, Amancio Carnero, Marco Perez, David Marcilla, Jose A. Lopez-Martin, Antonio Casado Herraez, Rosa Maria Alvarez Alvarez, Josefina Cruz Jurado, Anna Estival-Gonzalez, Patricio Ledesma, Nadia Hindi
Publikováno v:
Journal of Clinical Oncology. 40:11511-11511
11511 Background: CDK4/6 inhibitors showed a favorable progression-free survival (PFS) in DD LPS, a sarcoma bearing 12q 13-15 amplicon that implies CDK4 amplification. The median PFS was 4 and 7 months (m) for palbociclib and abemaciclib, respectivel
Autor:
Beatriz García, Yolanda García-Mesa, Luis M. Quirós, Jesús Merayo, Olivia García-Suárez, Iván Fernández-Vega, Carla Martín, Sara González-Fernández, Natalia Pérez-López, Maria Pilar Solis-Hernandez
Publikováno v:
Scopus
Cells
Volume 10
Issue 8
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Cells, Vol 10, Iss 2002, p 2002 (2021)
Cells
Volume 10
Issue 8
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Cells, Vol 10, Iss 2002, p 2002 (2021)
Small leucine-rich proteoglycans (SLRPs) regulate different processes and undergo significant alterations in various diseases. Colon carcinomas (CCs) are heterogeneous pathologies with important clinical and molecular differences depending on their l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4d623e903a125ebb2ef44708a7fcdf
http://hdl.handle.net/10651/63709
http://hdl.handle.net/10651/63709
Autor:
Alejandro González, Diego A. Gómez, Emilio Esteban, J. del Río Fernández, Noemi Villanueva, Carlos Alvarez-Fernandez, Debora Corina Contreras Toledo, P. Jiménez-Fonseca, Sena Valcárcel González, Clara Iglesias Gomez, Alfonso Revuelta, M. Izquierdo, Maria Pilar Solis-Hernandez, Sara Fernandez Arrojo, V. V. Durantez, Luka Mihic Góngora
Publikováno v:
Journal of Clinical Oncology. 39:e24098-e24098
e24098 Background: Patient reported outcomes measures (PROMs) represent a tool to objectively assess the health of cancer patients. PROMs may complement oncological evaluations by adding patients’ perspectives on their care priorities. Aim: to addr
Optimizing the febrile neutropenia care process in cancer patients in a third level Spanish hospital
Autor:
Emilio Esteban, Carlos Alvarez Fernandez, Jorge del Río Fernández, Maria Muniz Castrillo, Marta Izquierdo Manuel, Maria Pilar Solis-Hernandez, Luka Mihic Góngora, Sara Fernandez Arrojo, Noemi Villanueva, Debora Corina Contreras Toledo, Sena Valcárcel González, Paula Jiménez Fonseca, Clara Iglesias Gomez, Yolanda Fernandez Perez, Oscar Alfredo Castillo Trujillo, Alfonso Revuelta, David Gomez, Isabel Palacio Vázquez, Juan Luis García Llano
Publikováno v:
Journal of Clinical Oncology. 38:e14034-e14034
e14034 Background: Cancer patients under cytotoxic treatment with fever used to have an average time of antibiotics administration of 11h (median 3h43min) when admitted and identified at the Emergency Room Service in the third level Central Universit
Autor:
L. Faez, Noemi Villanueva, Teresa Quiñones Roces, Sara Gonzalez Lolo, Carmen Méndez, Lucia Rodríguez, Esther Uriol, Clara Iglesias, Sena Valcárcel González, Alfonso Revuelta, Jorge del Río Fernández, Sara Fernandez Arrojo, David Gómez, Carlos Alvarez-Fernandez, Maria Pilar Solis-Hernandez, Emilio Esteban
Publikováno v:
Journal of Clinical Oncology. 37:665-665
665 Background: It is widely known the causal relationship establised between tobacco use and the development of renal cancer is widely known. Nevertheless, the impact of smoking on the efficacy and safety of anti-angiogenic drugs is unclear. Sunitin
Autor:
David Gómez, Lucía Rodríguez Arias, Sara Fernandez, L. Faez, Maria Pilar Solis-Hernandez, Debora Corina Contreras Toledo, Sena Valcárcel González, Luka Mihic Góngora, Clara Iglesias, Felipe Jose Alvarez Manceñido, Rodrigo Ignacio Cereceda García, Emilio Esteban, Jorge del Río Fernández, Verónica Blanco Lorenzo, Alfonso Revuelta
Publikováno v:
Journal of Clinical Oncology. 37:603-603
603 Background: the prognosis and treatment of advanced RCC has improved over the last decade due to a number of effective anti-angiogenic and immune checkpoint inhibitors (ICPI) therapies. Certain clinical factors, such as low Karnofsky status (≤